Brief: IX Biopharma Proposes Renounceable Non-Underwritten Rights Issue
21/06/2021 15:19
June 21 (Reuters) - IX Biopharma Ltd IXBI.SI :
* PROPOSES RENOUNCEABLE NON-UNDERWRITTEN RIGHTS ISSUE OF UP
TO
48.8 MILLION NEW SHARES
* ISSUE PRICE OF S$0.20 FOR EACH SHARE
Source text for Eikon: ID:nSNYfJZx
Further company coverage: IXBI.SI
(Reuters.Briefs@thomsonreuters.com)
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture